Just another WordPress site

Correlates of continued cannabis use during pregnancy

Sep 27, 2022

Abstract

Background

Cannabis use is increasingly common among pregnant women despite concern that it may be linked to adverse maternal and infant outcomes. Determining whether variables associated with cannabis use predict whether women continue or quit using during pregnancy may inform strategies to reduce prenatal use.

Methods

Pregnant women who regularly used cannabis before pregnancy (n = 296) were recruited via Facebook. After finding out they were pregnant, 41 % reported quitting, 13 % quit then relapsed, 32 % reduced use, and 15 % continued use at the same rate. Differences among these four cannabis use status groups (quit, relapsed, reduced, continued) in sociodemographics, cannabis use, cigarette use, perceived risk/benefit, delay discounting, and communications about cannabis with their doctor were assessed.

Results

Compared to those who quit, continuing use during pregnancy was associated with being unemployed (Relative Risk (RR) = .32, 95 %CI [.13, .78]), using cigarettes pre-pregnancy (RR = 3.43, 95 %CI [1.32, 8.94]), being in an earlier trimester (RR = 4.38, 95 %CI [1.18, 16.23]), less perceived risk (RR = .79, 95 %CI [.74, .85]), and more days per week of use pre-pregnancy (RR = .10, 95 %CI [.01, .84]). Unintended pregnancy, shorter time to cannabis use after waking pre-pregnancy, using cannabis more times per day pre-pregnancy, and greater perceived benefits of use had significant bivariate associations with continued use during pregnancy, but did not retain significance in a multinomial model.

Conclusions

Identification of these correlates provides potential targets for prevention of or intervention for prenatal cannabis use. However, much more research is needed to understand prenatal cannabis use and its effects in order to better educate women and healthcare providers, and to design optimal public health strategies.

Webmaster

Webmaster

Other Posts

Recommended Approaches to Evaluate Methodologies and Technologies for the Detection of Cannabis-Impaired Driving

In September 2023, New York State Department of Health (DOH) issued a Request for Information (RFI) regarding methodologies and technologies used for the detection and assessment of driving under-the-influence of cannabis (DUIC). The RFI purpose is to assist the DOH in assessing the current state of research on impairment due to cannabis ingestion, and to review current devices that can be used to detect impairment. Moreover, the DOH is seeking to identify research institutions in higher education that are currently performing this type of research.

read more

Maryland Medical Cannabis Patient Survey Report 2022

The Maryland Medical Cannabis Commission sponsored this survey and report from Cannabis Public Policy Consulting (CPPC) to examine patterns of use, perceptions of risk and benefit, and occurrence of high-risk
behaviors related to cannabis use in the medical cannabis patient population. More than 13,000 medical cannabis patients took part in the survey, which was conducted in September 2022, prior to the General Election referendum to legalize adult use in the state. A second, post referendum survey is planned for fall 2023.

read more

STAY INFORMED ON CPPC'S RESEARCH AND PROJECTS